Financhill
Back

Predictive Oncology Quote, Financials, Valuation and Earnings

Predictive Oncology Price Quote

$0.92
+0.02 (+2.22%)
(Updated: September 16, 2024 at 2:55 PM ET)

Predictive Oncology Key Stats

Sell
37
Predictive Oncology (POAI) is a Sell

Day range:
$0.88 - $0.93
52-week range:
$0.85 - $4.10
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.16
P/B ratio:
1.47%

Volume:
67.8K
Avg. volume:
129.4K
1-year change:
-73.29%
Market cap:
$6M
Revenue:
$1.8M
EPS:
$-3.35

How Much Does Predictive Oncology Make?

Is Predictive Oncology Growing As A Company?

  • What Is Predictive Oncology's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.43%
  • What Is Predictive Oncology's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Predictive Oncology Stock Price Performance

What Is Predictive Oncology 52-Week High & Low?

Predictive Oncology Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Predictive Oncology?

Is Predictive Oncology Cash Flow Positive?

  • What Is POAI Cash Flow From Operations?
    Cash flow from operations (TTM) is -$12.8M
  • What Is Predictive Oncology’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $3.4M
  • What Is Predictive Oncology’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$6.1K

Predictive Oncology Return On Invested Capital

  • Is Management Doing A Good Job?
    POAI return on invested capital is -161.36%
  • What Is Predictive Oncology Return On Assets?
    ROA measures how assets are converting to revenues and is -93.92%
  • What Is POAI Return On Equity?
    ROE is a measure of profitability and is -164.1%

Predictive Oncology Earnings Date & Stock Price

Predictive Oncology Competitors

  • Who Are Predictive Oncology's Competitors?
    Below is a list of companies who compete with Predictive Oncology or are related in some way:
    • Perspective Therapeutics Inc (CATX)
    • InfuSystems Holdings Inc (INFU)
    • Retractable Technologies Inc (RVP)
    • Catheter Precision Inc (VTAK)
    • Xtant Medical Holdings Inc (XTNT)

Predictive Oncology Dividend Yield

Predictive Oncology Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: -43.13% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 3.00
Upside from Last Price: 233.33%

Major Shareholders

  • How many POAI shares are owned by institutional investors?
    348K POAI shares are owned by institutional investors
  • How many POAI shares are owned by insiders?
    5.8M POAI shares are owned by insiders